You are here: Home: CCU 3 | 2003: Yehuda Patt, MD: Select publications


Select publications

Publications discussed by Dr Patt

Douillard JY et al. Metastatic colorectal cancer: Integrating irinotecan into combination and sequential chemotherapy. Ann Oncol 2003;14(Suppl 2): ii7-ii12. Abstract

Falcone A et al. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: A pilot study in patients with metastatic colorectal cancer. J Clin Oncol 2002;20:4006-14. Abstract

Goldberg RM et al. N9741: oxaliplatin (Oxal) or CPT-11 + 5-fluorouracil (5FU)/leucovorin (LV) or oxal + CPT-11 in advanced colorectal cancer (CRC). Updated efficacy and quality of life (QOL) data from an intergroup study. Proc ASCO 2003;Abstract 1009.

Patt YZ et al. Capecitabine plus irinotecan for chemotherapy-naïve patients with metastatic colorectal cancer (MCRC): US multicenter phase II trial. Proc ASCO 2003;Abstract 1130.

Patt YZ et al. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 2003;21:421-7. Abstract

 

Table of Contents Top of Page

Home

Editor’s Note
 
Norman Wolmark, MD
- Select publications
 
John Zalcberg, MB, BS, PhD, FRACP
- Select publications
 
Yehuda Patt, MD
- Select publications
 
Lawrence D Wagman, MD, FACS
- Select publications

Faculty Disclosures

A CME Audio Series and Activity

Editor's office

 

Terms of use and general disclaimer
© NL Communications, Inc. 2003. All rights reserved.